BSX vs RMD · P/E 20, rev $10.65B vs P/E 29, rev $5.65B
Boston Scientific Corp (BSX) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the BSX and RMD stock pages for the full models.
Not investment advice.